Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TMCI
TMCI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TMCI News
Treace Medical Concepts Q1 2026 Earnings Call Insights
2d ago
seekingalpha
Treace Medical Q1 Earnings Beat Expectations
2d ago
seekingalpha
Artivion Shares Surge 5.3% on FDA Approval News
Apr 08 2026
NASDAQ.COM
Treace Medical Concepts Q4 2025 Earnings Call Insights
Feb 27 2026
seekingalpha
Treace Medical Reports Q4 Results and 2026 Guidance
Feb 27 2026
seekingalpha
Treace Medical Reports 2025 Financial Highlights
Feb 27 2026
Newsfilter
UFP Technologies Reports Quarterly Earnings Beat
Feb 25 2026
NASDAQ.COM
Treace Medical Concepts to Release Q4 and Full Year 2025 Financial Results
Feb 12 2026
Newsfilter
Treace Medical Concepts Reports Q4 2025 Revenue of $62.1M to $62.5M, Beating Consensus
Jan 14 2026
seekingalpha
Treace Completes First Surgery Using Lapiplasty®Lightning™ Technology
Jan 08 2026
Globenewswire
Treace Medical CEO to Present at J.P. Morgan Healthcare Conference on January 14, 2026
Dec 30 2025
Globenewswire
Post-Market Winners: A Calm Trading Day Highlighted by a Notable Biotech Rise
Dec 17 2025
NASDAQ.COM
Johnson Fistel, PLLP Probes Allegations for Long-Term Investors in Quantum Computing Inc. (QUBT), Quanex Building Products Corporation (NX), Treace Medical Concepts, Inc. (TMCI), and BigBear.ai Holdings, Inc. (BBAI)
Dec 01 2025
Globenewswire
UBS Keeps Neutral Rating on Treace Medical Concepts (TMCI)
Nov 08 2025
NASDAQ.COM
Nasdaq Drops More Than 100 Points as US Consumer Sentiment Declines in November
Nov 07 2025
Benzinga
Treace Medical (TMCI) Q3 2025 Earnings Call Transcript
Nov 07 2025
NASDAQ.COM
Show More News
